Stephen Stone, MD 🔬🧬🐁✏️
@stevestonedraws.bsky.social
120 followers 110 following 150 posts
Peds Endo & Physician Scientist | Amateur Medical Illustrator | Live Sketchnotes | Dabbles in Python | Tweets are my own | Reposts != Endorsement | bmc.link/DiabetesNinja | stonelab.wustl.edu
Posts Media Videos Starter Packs
stevestonedraws.bsky.social
Maternal diet shapes the next generation. Dr. Mike Thompson shared how obesogenic diets in mothers profoundly alter the gut microbiome and bile acid metabolism of offspring.
#PPI @washumedicine.bsky.social
@hepatocrinologist.bsky.social
stevestonedraws.bsky.social
Dr. Colin G. Nichols shared how the KATP channel drives both neonatal diabetes & congenital hyperinsulinism. 🧬 Key insights: SUR1 mutations, shifts in calcium sensitivity, & why diazoxide works (when sulfonylureas may not).
@washumedicine.bsky.social @colinnicholslab.bsky.social #EndoSky
stevestonedraws.bsky.social
Euglycemic DKA can develop in patients on SGLT2 inhibitors — even without diabetes. ⚠️ Important to counsel families on fasting and DKA symptoms as use of these meds grows in pediatric heart failure. @washumedicine.bsky.social
#Endocrinology #DiabetesCare #HeartFailure #MedTwitter
stevestonedraws.bsky.social
Sketchnote from Dr. Carmen Halabi’s talk:
👉 Lox is essential for elastin in large vessels
👉 Knockout = aortic aneurysms
👉 Early mortality in mice
👉 Why is the ascending aorta most at risk?
Big insights at the interface of genetics + vascular biology!
#Research @washumedicine.bsky.social
stevestonedraws.bsky.social
🌟 Grand Rounds with Dr. Megan Cooper 🌟
One patient’s story can unlock diagnoses for dozens more. 🧬

From inborn errors of immunity to targeted therapies, genome sequencing is transforming care for #PrimaryImmuneDeficiency.

#Genomics #PrecisionMedicine #Pediatrics #RareDisease
stevestonedraws.bsky.social
That’s a wrap on #ENDO2025!
Thank you to the incredible speakers, attendees, and organizers who made this week unforgettable.

Sketching my way through the science was a blast—what was your favorite?
@endocrinesociety.bsky.social
stevestonedraws.bsky.social
Christoffer Clemmensen’s #ENDO2025 talk forecasted what’s coming next in obesity pharmacotherapy:
💉 Dual/triple/quad agonists (GLP-1, GIP, amylin, glucagon)
🧠 NMDA receptor targets = neuroplasticity
🔬 ghrelin → prevents regain
📉 GLP-1/GIP/meranzin combo↓

@endocrinesociety.bsky.social
stevestonedraws.bsky.social
Robert Semple at #ENDO2025 is pushing boundaries with deep mutational scanning of the #insulin receptor:
🔬 Testing all possible variants
🧩 Critical insights into cysteine-rich domains
🧠 Epitope mapping + therapeutic responsiveness
@endocrinesociety.bsky.social
stevestonedraws.bsky.social
Vincent Harley at #ENDO2025 identified 2 novel genes in 46,XY DSD:
🧠 MAP3K7 kinase domain variants—Sertoli-specific, WNT-β-catenin disruption
🧬 DMRT3 variants—potential estrogen activation & gain-of-function
@endocrinesociety.bsky.social
#DSD #Genetics
stevestonedraws.bsky.social
Luca Persani on behalf of Federica Marelli presented cutting-edge models of thyroid hormone resistance at #ENDO2025:
🐟 Zebrafish = functional platform for VUS
📉 Easier to ID THRβ defects via TFT signature
📘 Guidelines -specific variant interpretation
@endocrinesociety.bsky.social
#ThyroidGenetics
stevestonedraws.bsky.social
Tracy Rankin’s #ENDO2025 session was full of practical grant-writing advice:
✅ Know when to contact your program vs. review officer
✅ Tailor your career dev plan for Ks
✅ Plan for conceptual + technical pitfalls
✅ Be aware of timelines—and stay resilient!

@endocrinesociety.bsky.social #NIDDK
stevestonedraws.bsky.social
Jens Holst at #ENDO2025 called incretins “the silver bullet”—and for good reason:
💡 Modified GLP-1 has powerful central effects
🫀 Broad benefits: ↓ CV risk, ↓ inflammation, sleep apnea, MASH, Cancer?
🔑 Lifestyle change is key to keeping the weight off.
@endocrinesociety.bsky.social
stevestonedraws.bsky.social
🚨 Poster alert! I’ll be presenting MON-573 at #ENDO2025 today from 12–1:30 PM.
🧬 Come learn about novel GLUT4 (SLC2A4) variants in atypical young-onset diabetes
📊 Proud to be part of the #RADIANT -study and this incredible research community.
@endocrinesociety.bsky.social
stevestonedraws.bsky.social
At #ENDO2025, dinner with some of the most brilliant and kind-hearted Peds Endos I’ve ever met.
These are the moments that make conferences meaningful—connection, mentorship, and shared purpose.
@endocrinesociety.bsky.social #PedsEndo
stevestonedraws.bsky.social
#ENDO2025 “Meet the Professors” session featured Onno Holleboom & Eveline Bruinstroop with updates on MASLD:
🧬 FGF21 analogs + PPARδ = emerging therapies
📊 FIT-4 score + FibroScan = easy, non-invasive tools
🧠 GLP-1s may help too
@endocrinesociety.bsky.social
#MASLD
stevestonedraws.bsky.social
At #ENDO2025, Iza Machado shared key data linking puberty timing to adult cardiometabolic health:
📍 Early menarche = ↑ CV risk
📍 Late menarche = ↑ coronary artery disease
📊 Based on a large population cohort from Brazil

@endocrinesociety.bsky.social
#PubertyMatters #ENDO2025
stevestonedraws.bsky.social
Found my dose on the wall!
137 mcg Synthroid, powering me since 1994.
Here’s to #ENDO2025, long-term hormone therapy, and stable thyroid vibes 🦋#LevothyroxineLife @endocrinesociety.bsky.social @abbvie.bsky.social
stevestonedraws.bsky.social
At #ENDO2025, Melanie Haines emphasized the need to monitor muscle and bone health in patients on GLP-1 therapy:
🏋️‍♀️ Muscle loss is an under-recognized concern
👵 Women + older adults face higher risk
🦴 Bone resorption via CTX?
Whole-patient care matters.
@endocrinesociety.bsky.social
stevestonedraws.bsky.social
Rossella Cannarella at #ENDO2025 highlighted how tirzepatide might address more than just weight:
🧬 Effective for metabolic hypogonadism
🍆 Boosts sexual function
👶 May hold promise for fertility
🔍 Could Sertoli-sperm cell signaling be key?
Big questions, big potential.
@endocrinesociety.bsky.social
stevestonedraws.bsky.social
Angela Rao at #ENDO2025 discussed GLP-1 use alongside bariatric surgery:
💊 Adjunctive therapy is not statistically significant yet—but may benefit Class IV obesity
🧩 Calls for individualized care plans
📝 Recommends pre- and post-op GLP-1
@endocrinesociety.bsky.social
stevestonedraws.bsky.social
At #ENDO2025, Christian Roth introduced KCN1—a novel antibody hitting GLP1, MCHR, and MC5R.
🔬 Rat studies show improved glucose tolerance, weight loss, and fewer GI side effects.
🤓 Also: Did you know rats can’t vomit?
Precision obesity therapy may have a new contender. @endocrinesociety.bsky.social
stevestonedraws.bsky.social
Nancy Cox at #ENDO2025 dropped truths about the intersection of genomics + EHR data:
📊 Medical phenome analysis at Vanderbilt is transforming rare disease discovery
📢 “A diagnosis isn’t truth—it’s data”
What does this mean for the future of precision endocrinology? @endocrinesociety.bsky.social
stevestonedraws.bsky.social
“Not just a library—a learning system.”
Sir Mark Caulfield at #ENDO2025 highlighted the 100,000 Genomes Project is transforming diagnostics
✅ NHS-wide integration
✅ 25% rare disease Dx rate
What if this was the future of newborn screening?
@endocrinesociety.bsky.social @markcaulfield.bsky.social
stevestonedraws.bsky.social
Opening #ENDO2025 with urgency and hope.
In his presidential address, John Newell-Price reminded us what matters most:
🧠 Science.
🌍 Inclusivity.
🗣️ Advocacy.
Follow @endocrinesociety.bsky.social for updates and reflections throughout the meeting.
stevestonedraws.bsky.social
Thrilled to be attending my very first #ENDO2025!
I’ll be sketching my way through the conference, translating the latest endocrine science into visual snapshots.
Let’s make this one to remember. Follow along: @endocrinesociety.bsky.social ✍️🧬🧠